» Authors » Shrinivas Rathod

Shrinivas Rathod

Explore the profile of Shrinivas Rathod including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 260
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Alfaifi S, Pareek V, Kim J, Rathod S, Hunter W, Leylek A, et al.
Lung Cancer Manag . 2025 Jan; :2367369. PMID: 39883102
Single-fraction stereotactic body radiation therapy (SF-SBRT) for peripheral lung tumors was reviewed. Medically inoperable peripheral lung tumors eligible for SF-SBRT 34 Gray were treated. Patient characteristics, treatment and toxicity parameters...
2.
Abrina J, Baker S, Cruz-Lim E, Chng N, Ye A, Rathod S, et al.
Pract Radiat Oncol . 2024 Sep; PMID: 39303778
Purpose: The optimal SABR treatment delivery schedule in stage I non-small cell lung cancer (NSCLC) remains unclear. This population-based study investigated grade ≥2 toxicity rates, local failure (LF), and overall...
3.
Shahhat S, Hanumanthappa N, Chung Y, Beck J, Koul R, Bashir B, et al.
Curr Oncol . 2022 Jul; 29(7):5097-5109. PMID: 35877264
In early 2017, the Canadian Partnership Against Cancer and CancerCare Manitoba undertook a comprehensive knowledge translation (KT) campaign to improve the utilization of single fraction radiotherapy (SFRT) over multiple fraction...
4.
Cheng J, Dubey A, Beck J, Sasaki D, Leylek A, Rathod S
3D Print Med . 2022 Mar; 8(1):8. PMID: 35348934
Background: Single field Orthovoltage radiation is an acceptable modality used for the treatment of nasal cutaneous cancer. However, this technique has dosimetric pitfalls and unnecessary excessive exposure of radiation to...
5.
Aduquaye M, Dube S, Bashir B, Chowdhury A, Ahmed N, Leylek A, et al.
Curr Oncol . 2022 Jan; 29(1):193-208. PMID: 35049693
Introduction: We evaluated the association of pre-treatment immunologic biomarkers on the outcomes of early-stage non-small-cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT). Materials And Methods: In...
6.
Siciarz P, Alfaifi S, Van Uytven E, Rathod S, Koul R, McCurdy B
Clin Transl Radiat Oncol . 2021 Oct; 31:50-57. PMID: 34632117
Purpose: To create and investigate a novel, clinical decision-support system using machine learning (ML). Methods And Materials: The ML model was developed based on 79 radiotherapy plans of brain tumor...
7.
Rittberg R, Banerji S, Kim J, Rathod S, Dawe D
Am J Clin Oncol . 2021 Oct; 44(12):629-638. PMID: 34628433
Central nervous system (CNS) metastasis will develop in 50% of small cell lung cancer (SCLC) patients throughout disease course. Development of CNS metastasis poses a particular treatment dilemma due to...
8.
Abdalmassih M, Bucher O, Rathod S, Dubey A, Kim J, Ahmed N, et al.
Cureus . 2020 Dec; 12(12):e11886. PMID: 33304707
Introduction The standard of care for early-stage non-small cell lung cancer (NSCLC) is surgery. However, for medical inoperable patients stereotactic body radiation therapy (SBRT) is an alternative method. The aim...
9.
Ahmed N, Owen J, Abdalmassih M, Khan J, Nugent Z, Qing G, et al.
Am J Clin Oncol . 2020 Oct; 44(1):10-17. PMID: 33105233
Objectives: Perioperative chemotherapy (P-CT) or neoadjuvant chemoradiation (C-RT) followed by surgical resection is the standard of care for locally advanced esophageal cancer (LAEC). We present an institutional review and outcome...
10.
Sananmuang T, Yu E, Su J, OSullivan B, Rathod S, Chan B, et al.
Laryngoscope . 2020 Oct; 131(4):E1162-E1171. PMID: 33002201
Objectives: To assess the prognostic value of pre-/post-radiotherapy (pre-/post-RT) radiologic lymph node (LN) features in human papillomavirus (HPV)-positive and HPV-negative oropharyngeal carcinoma (OPC) patients treated with definitive (chemo-)RT. Methods: Clinical...